MetLife（MET）株式概要
金融サービス会社であるメットライフ・インクは、世界中で保険、年金、従業員福利厚生、資産運用サービスを提供している。 詳細
MET Community Fair Values
Create NarrativeSee what 48 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
MetLife, Inc. 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | US$83.27 |
| 52週高値 | US$85.29 |
| 52週安値 | US$67.33 |
| ベータ | 0.77 |
| 1ヶ月の変化 | 7.17% |
| 3ヶ月変化 | 10.57% |
| 1年変化 | 5.37% |
| 3年間の変化 | 61.22% |
| 5年間の変化 | 25.20% |
| IPOからの変化 | 464.54% |
最新ニュース
Seeking Alpha • May 24
MetLife: Time To Go Long The Common Shares And 6.35% Yielding Preferreds
Summary MetLife delivers robust adjusted income, supporting a bullish stance on common shares and fixed-rate preferreds. MET's preferred dividend payout ratio remains low, with $24.5B in common equity providing strong downside protection for preferred holders. Series A floating-rate preferreds yield 5.45%-5.5%, attractive if short-term rates rise, but fixed-rate Series F offers a higher current yield. I rate MET common and Series F preferreds as a "buy," maintaining "hold" on Series A preferreds pending a significant SOFR increase. Read the full article on Seeking Alpha
ナラティブの更新 • May 03
MET: Share Repurchases And Dividend Increases Will Support Future Upside Potential
Analysts have slightly adjusted their fair value estimate for MetLife, nudging the implied price target from about $89.06 to $89.31. This reflects modest tweaks to assumptions around the discount rate, long term revenue growth, profit margin and future P/E multiples.Recent updates
Seeking Alpha • May 24
MetLife: Time To Go Long The Common Shares And 6.35% Yielding Preferreds
Summary MetLife delivers robust adjusted income, supporting a bullish stance on common shares and fixed-rate preferreds. MET's preferred dividend payout ratio remains low, with $24.5B in common equity providing strong downside protection for preferred holders. Series A floating-rate preferreds yield 5.45%-5.5%, attractive if short-term rates rise, but fixed-rate Series F offers a higher current yield. I rate MET common and Series F preferreds as a "buy," maintaining "hold" on Series A preferreds pending a significant SOFR increase. Read the full article on Seeking Alphaナラティブの更新 • May 03
MET: Share Repurchases And Dividend Increases Will Support Future Upside Potential
Analysts have slightly adjusted their fair value estimate for MetLife, nudging the implied price target from about $89.06 to $89.31. This reflects modest tweaks to assumptions around the discount rate, long term revenue growth, profit margin and future P/E multiples.ナラティブの更新 • Apr 17
MET: Share Repurchases Following Index Exit Will Support Future Upside Potential
Analysts have slightly reduced their MetLife fair value estimate to $89.06 from $90.50, reflecting minor adjustments to assumptions for the discount rate, revenue growth, profit margin, and future P/E ratio that refine their outlook for the shares. What's in the News MetLife has been dropped from the S&P 100 index, which may influence how some index funds and benchmarks gain exposure to the stock (Key Developments).ナラティブの更新 • Apr 01
MET: Share Repurchases And Index Exit Will Shape Future Upside Potential
Analysts have trimmed their average MetLife price target slightly to $90.50 from $90.73, citing updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News MetLife, Inc.ナラティブの更新 • Mar 18
MET: Share Repurchases Will Support Future Upside Potential
Analysts have slightly adjusted their price target for MetLife to $90.73 from $90.93, reflecting updated views on discount rates, revenue growth, profit margins, and future price-to-earnings (P/E) assumptions. What's in the News MetLife reported that from October 1, 2025 to January 31, 2026 it repurchased 7,608,263 shares, representing 1.15% of shares, for a total of US$600 million under its current buyback program (Key Developments).ナラティブの更新 • Mar 04
MET: Buybacks And Retirement Income Agreements Will Drive Future Upside
Analysts have trimmed their price target on MetLife to about $90.93 from roughly $92.93. This reflects updated views on slightly lower expected revenue growth, a modestly softer profit margin, a higher discount rate, and a largely unchanged future P/E assumption.ナラティブの更新 • Dec 16
MET: Retirement Income Agreements Will Drive Future Upside In Earnings Power
Analysts have marginally reduced their price target on MetLife to approximately 92.93 dollars from 93 dollars, citing a slightly higher assumed discount rate. This more than offsets modest improvements in forecast profit margins and valuation multiples.ナラティブの更新 • Nov 07
MET: Revenue Will Advance On New Retirement Income And Employee Support Agreements
Analysts have slightly reduced their price target for MetLife from $93.33 to $93.00, reflecting minor adjustments to discount rate and profit margin assumptions. They maintain a positive outlook on revenue growth.ナラティブの更新 • Oct 24
Digital Expansion And Employee Support Benefits Will Drive Outperformance Ahead
Analysts have modestly raised their price target for MetLife, increasing it from $93.00 to $93.33 per share. They cited slight improvements in projected revenue growth and profit margins as the reason for the adjustment.ナラティブの更新 • Oct 09
International Demand And Digital Transformation Will Fuel Success
Analysts have raised their fair value estimate for MetLife from $91.86 to $93.00. This reflects slight adjustments to discount rates and growth assumptions.ナラティブの更新 • Sep 04
International Demand And Digital Transformation Will Fuel Success
With no change in revenue growth forecasts or discount rate, MetLife’s fair value estimate remains steady at $91.86. What's in the News MetLife will redeem all outstanding shares of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, at $1,000 per share; dividends of $19.250 per share will be paid separately, and all further dividends cease post-redemption.分析記事 • Jun 11
It's Unlikely That MetLife, Inc.'s (NYSE:MET) CEO Will See A Huge Pay Rise This Year
Key Insights MetLife's Annual General Meeting to take place on 17th of June Salary of US$1.50m is part of CEO Michel...Seeking Alpha • Feb 11
MetLife: Double-Digit EPS Growth With A Single-Digit P/E, Strong Chart
Summary MetLife, Inc. is rated a buy due to its solid value, above-market dividend yield, and favorable technical chart despite recent earnings misses. Insurance stocks, including MET, have lagged behind the Financials sector and S&P 500, with premium increases expected to slow as consumers react to rising costs. MET's 2025 outlook is positive, with analysts forecasting over 17% EPS growth and 5%-6% revenue growth, despite recent underperformance in certain segments. Key risks include lower stock prices, falling interest rates, and regulatory challenges, but MET's strong investment income and share buybacks are positive factors. Read the full article on Seeking AlphaSeeking Alpha • Nov 26
MetLife Upgraded To Buy As Financials And Insurance Show Further Upside Potential
Summary MetLife stock gets upgraded to a buy, from my prior hold rating, as indicators point to further share price potential in the financials sector, as well as the insurance subsector. Data points to future continued demand for annuities and life insurance, and MetLife has in Q3 achieved new organic customer growth in 2 key businesses. Although its dividend yield is not stellar vs. peers, it has a 10-year track record of proven dividend growth, something it has potential to continue. Even though it is trading at a 10-year high, it remains undervalued on P/E and EV/EBITDA vs. peers, so continues to present a buy opportunity. Read the full article on Seeking AlphaSeeking Alpha • Sep 23
MetLife: One Of The Best Life Insurance Stocks
Summary MetLife's strong financial performance, with a 17.5% increase in adjusted EPS and a 15.2% rise in book value, makes it an attractive investment. Despite comparable performance to Aflac, MetLife's lower valuation offers better value for shareholders. MetLife's growing dividend yield and robust share buyback program enhance shareholder value, with ample cash reserves supporting future buybacks. Risks include potential commercial real estate portfolio defaults and market volatility, but MetLife's strong fundamentals and attractive valuation make it a compelling choice. Read the full article on Seeking AlphaSeeking Alpha • Jul 09
Higher For Longer? Consider MetLife's Preferred Shares With A 6.6% Yield
Summary MetLife's preferred shares, particularly the Series A with floating dividends, offer potential for investors in a 'higher for longer' inflation and interest rate environment. MetLife's strong financial performance in Q1 2021, with net profit covering preferred dividends by less than 8%. Series A preferred shares have a minimum 4% floor for dividends, with potential for higher yields based on 3 month SOFR rate adjustments. Read the full article on Seeking AlphaSeeking Alpha • Jun 26
MetLife Looks Like An Undervalued Property In An Unpopular Neighborhood
Summary MetLife shares have outperformed peers, but life insurance stocks have not really been in favor given concerns about CRE losses and rate cuts. Higher rates have allowed MetLife to reprice its investment portfolio at higher rates and sell more spread products, and the benefits will last even as rates fall. There are understandable concerns about MetLife's CRE exposure (office in particular), as the insurer is overweight here, but losses will take years to materialize and can be absorbed. MetLife's focus on profitable core businesses like group life and health, pension risk transfer, and international markets should lead to steady growth and returns for investors. This is something of a contrarian call given weak sector sentiment, but MetLife's differentiated model and ability to out-earn its cost of equity should drive outperformance. Read the full article on Seeking AlphaSeeking Alpha • Apr 18
MetLife: Healthy But Lacks Clear Advantages
Summary MetLife has experienced a decade of light shrinking instead of growth. This started as early as 2015 and was attributed to increased competition and a decrease in annuity sales, but this never seemed to improve. With their current size, competitive hurdles, and lack of clear targets for growth internationally, shares of MET will likely only give mediocre returns at best. Read the full article on Seeking Alpha株主還元
| MET | US Insurance | US 市場 | |
|---|---|---|---|
| 7D | 2.7% | -0.7% | 2.5% |
| 1Y | 5.4% | -8.8% | 26.4% |
業界別リターン: MET過去 1 年間で-8.8 % の収益を上げたUS Insurance業界を上回りました。
リターン対市場: METは、過去 1 年間で26.4 % のリターンを上げたUS市場を下回りました。
価格変動
| MET volatility | |
|---|---|
| MET Average Weekly Movement | 3.4% |
| Insurance Industry Average Movement | 4.4% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.1% |
安定した株価: MET 、 US市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。
時間の経過による変動: METの 週次ボラティリティ ( 3% ) は過去 1 年間安定しています。
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1999 | 46,000 | Michel Khalaf | www.metlife.com |
金融サービス会社であるメットライフ・インクは、世界中で保険、年金、従業員福利厚生、資産運用サービスを提供している。メットライフ生命は6つのセグメントで事業を展開している：グループ・ベネフィット、リタイヤメント＆インカム・ソリューションズ、アジア、ラテンアメリカ、欧州・中東・アフリカ、メットライフ・ホールディングスの6つのセグメントで事業を展開している。同社は生命保険、歯科保険、団体短期・長期障害保険、有給家族・医療休暇保険、個人障害保険、傷害・健康保険、視力保険、ペット保険、プリペイド法律プラン、雇用主への事務サービスのみの手配、一般・特別勘定・総合金利保証契約、プライベート変動金利積立契約を提供している。また、年金リスク移転、機関投資家向け収入年金、仕組債、資本市場投資商品、その他、退職後給付の資金調達のための生命保険商品や資金調達契約、役員向け非適格給付プログラムの資金調達に使用される会社、銀行、信託所有の生命保険などの商品・サービスも提供している。加えて、定額年金、指数連動年金、変額年金、年金商品、定期貯蓄商品、終身・定期保険、養老保険、終身・変額保険、団体生命保険商品、長寿保険および積立再保険ソリューション、信用保険商品、入院、がん、危篤、所得保障、定期医療払い戻し制度をカバーする傷害・健康商品、長期医療サービスに対する保障を提供している。同社は1999年に法人化され、ニューヨーク州ニューヨークを拠点としている。
MetLife, Inc. 基礎のまとめ
| MET 基礎統計学 | |
|---|---|
| 時価総額 | US$54.09b |
| 収益（TTM） | US$3.43b |
| 売上高(TTM) | US$77.58b |
15.6x
PER（株価収益率0.7x
P/SレシオMET は割高か？
公正価値と評価分析を参照収益と収入
| MET 損益計算書（TTM） | |
|---|---|
| 収益 | US$77.58b |
| 売上原価 | US$59.15b |
| 売上総利益 | US$18.43b |
| その他の費用 | US$15.00b |
| 収益 | US$3.43b |
直近の収益報告
Mar 31, 2026
次回決算日
該当なし
| 一株当たり利益（EPS） | 5.34 |
| グロス・マージン | 23.75% |
| 純利益率 | 4.43% |
| 有利子負債／自己資本比率 | 178.0% |
MET の長期的なパフォーマンスは？
過去の実績と比較を見る| MetLife 配当日 | |
|---|---|
| 配当落ち日 | May 12 2026 |
| 配当支払日 | Jun 09 2026 |
| 配当落ちまでの日数 | 15 days |
| 配当支払日までの日数 | 13 days |
MET 配当は確実ですか？
MET 配当履歴とベンチマークを見る企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/05/26 09:02 |
| 終値 | 2026/05/26 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
MetLife, Inc. 9 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。32
| アナリスト | 機関 |
|---|---|
| Jacob Kilstein | Argus Research Company |
| Jay Gelb | Barclays |
| Taylor Scott | Barclays |